Pharmaceutical Development and Regulation

Acknowledgement
pp. 223-223(1)
Author: Adis International Limited

The New US Federal Privacy Rules and Impact on Research
pp. 225-230(6)
Author: Radensky P.W.

Postmarketing Drug Safety Surveillance: An Overview of Regulatory Issues
pp. 231-244(14)
Authors: Wu J.H.; Fung M.C.; Kwong K.; Hornbuckle K.; Muniz E.

Regulation of Herbal and Homeopathic Medicines: An Overview
pp. 245-259(15)
Authors: Briggs C.J.; Norrie O.

Practical Tools and Techniques for Project Planning and Control in Clinical Research
pp. 261-268(8)
Author: Wills D.R.

Recruitment and Retention Strategies for Clinical Trials in Alzheimer’s Disease
pp. 269-276(8)
Authors: Sabbagh M.N.; Thompson N.; Tweedy D.; Stipho-Majeed S.; Kawas C.; Connor D.J.

Intellectual Property Right Protection for Pharmaceuticals in Developing Countries: A Case Study of Administrative Protection in China
pp. 277-282(6)
Authors: Wang Y.R.; Ji L.; Lin Y.A.

Pharmaceutical Decisions, New Developments and Proposed Regulations: From the Food Drug Cosmetic Law Reporter
pp. 283-286(4)
Author: Adis International Limited